| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5926942 | American Heart Journal | 2014 | 8 Pages |
Abstract
High residual platelet reactivity after clopidogrel administration is strongly associated with 1-year MACE-free survival. Routine measurement of platelet reactivity and thorough monitoring of patients with HPR after OPCAB are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Young-Nam MD, PhD, Gijong MD, PhD, Sak MD, PhD, Hyun-Chel MD, Kyung-Jong MD, PhD,